Pulse Biosciences, Inc. provided preliminary earnings Guidance for the three months ended June 30, 2024. For the period, the company expects GAAP net loss in the range of $10.7 million to $12.7 million.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
18.73 USD | -4.00% |
|
+26.26% | +52.04% |
15/07 | Pulse Biosciences Enters $60 Million Equity Distribution Agreement | MT |
15/07 | Pulse Biosciences, Inc. Provides Preliminary Earnings Guidance for the Three Months Ended June 30, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
+52.04% | 119.46Cr | |
+3.92% | 21TCr | |
+8.23% | 18TCr | |
+28.99% | 16TCr | |
+34.94% | 11TCr | |
+2.55% | 6.65TCr | |
+14.52% | 5.39TCr | |
-6.47% | 4.63TCr | |
-2.98% | 3.82TCr | |
+6.30% | 3.66TCr |
- Stock Market
- Equities
- PLSE Stock
- News Pulse Biosciences, Inc.
- Pulse Biosciences, Inc. Provides Preliminary Earnings Guidance for the Three Months Ended June 30, 2024